Erratum: Prefrontal GABA levels in cocaine-dependent subjects increase with pramipexole and venlafaxine treatment (Psyhopharmacology (2005) 182, (516-526) DOI: 10.1007/s00213-005-0121-5));Prefrontal GABA levels in cocaine-dependent subjects increase with pramipexole and venlafaxine treatment

Psychopharmacology

Volumn 182, Issue 4, 2005, Pages 516-526

  Streeter, Chris C ^a,b,c,d   Hennen, John ^c,d   Ke, Yong ^c,d   Jensen, J Eric ^c,d   Sarid Segal, Ofra ^a,b   Nassar, Leanne E ^c   Knapp, Clifford ^a   Meyer, Angela A ^b   Kwak, Tae ^a   Renshaw, Perry F ^a,c,d   Ciraulo, Domenic A ^a,b,d  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HealthCare System   (United States)

^c MCLEAN HOSPITAL   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Addiction severity index; Antidepressant; Cocaine; GABA; MRS; Pramipexole; Prefrontal; Spectroscopy; Treatment; Venlafaxine

Indexed keywords

4 AMINOBUTYRIC ACID; PLACEBO; PRAMIPEXOLE; VENLAFAXINE;

ADULT; ARTICLE; BRAIN LEVEL; CLINICAL TRIAL; COCAINE DEPENDENCE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DEPENDENCE; FEMALE; HUMAN; MALE; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RANDOMIZED CONTROLLED TRIAL;

EID: 26844521658     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-005-0236-8     Document Type: Erratum

References (68)

1. (2003) Physicians' desk reference, 57th edn. Medical Economics Co., Medical Economics Co
2. Alexander GE, DeLong MR, Strick PL (1986) Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu Rev Neurosci 9:357-381
3. Arvat E, Maccagno B, Ramunni J, Di Vito L, Gianotti L, Broglio F, Benso A, Deghenghi R, Camanni F, Ghigo E (1998) Effects of dexamethasone and alprazolam, a benzodiazepine, on the stimulatory effect of hexarelin, a synthetic GHRP, on ACTH, cortisol and GH secretion in humans. Neuroendocrinology 67:310-316
4. American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders, 4th edn. American Psychiatric Association, Washington, DC
5. Aue W, Karhan J, Ernst R (1976) Homonuclear borad band decoupling and two-dimensional J-resolved NMR spectroscopy. J Chem Phys 64:4226-4227
6. Behar K, Rothman D, Spencer D, Petroff O (1994) Analysis of macromolecule resonances in 1H NMR spectra of human brain. Med Risk Manag 3:294-302
7. Behar KL, Rothman DL, Petersen KF, Hooten M, Delaney R, Petroff OA, Shulman GI, Navarro V, Petrakis IL, Charney DS, Krystal JH (1999) Preliminary evidence of low cortical GABA levels in localized 1H-MR spectra of alcohol-dependent and hepatic encephalopathy patients. Am J Psychiatry 156:952-954
8. Bhagwagar Z, Wylezinska M, Taylor M, Jezzard P, Matthews PM, Cowen PJ (2004) Increased brain GABA concentrations following acute administration of a selective serotonin reuptake inhibitor. Am J Psychiatry 161:368-370
9. 1H magnetic resonance spectroscopy. NMR Biomed 17:60-68
10. Bolla K, Funderburk F, Cadet J (2000) Differential effects of cocaine and cocaine alcohol on neurocognitive performance. Neurology 54:2285-2292
11. Brebner K, Childress A, Roberts D (2002) A potential role for GABA(B) agonists in the treatment of psychostimulant addiction. Alcohol Alcohol 37:478-484
12. Breiter HC, Gollub RL, Weisskoff RM, Kennedy DN, Makris N, Berke JD, Goodman JM, Kantor HL, Gastfriend DR, Riorden JP, Mathew RT, Rosen BR, Hyman SE (1997) Acute effects of cocaine on human brain activity and emotion. Neuron 19:591-611
13. Carr DB, Sesack SR (2000) GABA-containing neurons in the rat ventral tegmental area project to the prefrontal cortex. Synapse 38:114-123
14. Childress AR, Mozley PD, McElgin W, Fitzgerald J, Reivich M, O'Brien CP (1999) Limbic activation during cue-induced cocaine craving. Am J Psychiatry 156:11-18
15. Choi C, Coupland N, Hanstock C, Ogilvie C, Higgins A, Gheorghiu D, Allen P (2005) Brain GABA measurement by proton double quantum filtering with selective J rewinding. Med Risk Manag, in press
16. Ciraulo D, Sarid-Segal O, Knapp C, Ciraulo A, LoCastro J, Bloch D, Montgomery A, Leiderman D, Elkashef A (2005) Efficacy screening trials of paroxetine, pentoxifylline, riluzole, pramipexole, and venlafaxine in cocaine dependence. Addictions S1:12-22
17. Dackis C, O'Brien C (2001) Cocaine dependence: a disease of the brain's reward centers. J Subst Abuse Treat 21:111-117
18. de Lima MS, de Oliveira Soares BG, Reisser AA, Farrell M (2004) Pharmacological treatment of cocaine dependence: a systematic review. Addiction 97:931-949
19. Dewey SL, Chaurasia CS, Chen CE, Volkow ND, Clarkson FA, Porter SP, Straughter-Moore RM, Alexoff DL, Tedeschi D, Russo NB, Fowler JS, Brodie JD (1997) GABAergic attenuation of cocaine-induced dopamine release and locomotor activity. Synapse 25:393-398
20. Ernst R, Bodenhausen G, Wokaun A (1987) Principles of nuclear magnetic resonance in one and two dimensions. Clarendon Press, Oxford
21. First MB, Spitzer R, Gibbon M, Williams J (1995) Structured clinical interview for DSM-IV Axis I Disorders: patient edition (SCID-I/P, Version 2.0). Biometric Research Dept, New York State University, New York
22. Goddard A, Mason G, Almai A, Rothman D, Behar K, Petroff O, Charney D, Krystal J (2001) Reductions in occipital cortex GABA levels in panic disorder detected with 1h-magnetic resonance spectroscopy. Arch Gen Psychiatry 58:556-561
23. Gonzalez G, Sevarino K, Sofuoglu M, Poling J, Oliveto A, Gonsai K, George TP, Kosten TR (2003) Tiagabine increases cocaine-free urines in cocaine-dependent methadone-treated patients: results of a randomized pilot study. Addiction 98:1625-1632
24. Grobin A, Deutch A (1998) Dopamine regulation of extracellular gamma-aminobutyric acid levels in the prefrontal cortex of the rat. J Pharmacol Exp Ther 285:350-357
25. Grottoli S, Arvat E, Gauna C, Maccagno B, Ramunni J, Giordano R, Maccario M, Deghenghi R, Ghigo E (2000) Alprazolam, a benzodiazepine, blunts but does not abolish the ACTH and cortisol response to hexarelin, a GHRP, in obese patients. Int J Obes Relat Metab Disord 24(Suppl 2):S136-S137
26. Herz A (1997) Endogenous opioid systems and alcohol addiction. Psychopharmacology 129:99-111
27. Hetherington HP, Newcomer BR, Pan JW (1998) Measurements of human cerebral GABA at 4.1-T using numerically optimized editing pulses. Magn Reson Med 39:6-10
28. Hirschfeld RM, Keller MB, Panico S, Arons BS, Barlow D, Davidoff F, Endicott J, Froom J, Goldstein M, Gorman JM, Marek RG, Maurer TA, Meyer R, Phillips K, Ross J, Schwenk TL, Sharfstein SS, Thase ME, Wyatt RJ (1997) The national depressive and manic-depressive association consensus statement on the undertreatment of depression. JAMA 277:333-340
29. Horst WD, Preskorn SH (1998) Mechanisms of action and clinical characteristics of three atypical antidepressants: venlafaxine, nefazadone, bupropion. J Affect Disord 51:237-254
30. Houser CR (1991) GABA neurons in seizure disorders: a review of immunocytochemical studies. Neurochem Res 16:295-308
31. Jayaram P, Steketee J (2005) Effects of cocaine-induced behavioral sensitization on GABA transmission within rat medial prefrontal cortex. Eur J Neurosci 21:2035-2039
32. Kalivas PW (1993) Neurotransmitter regulation of dopamine neurons in the ventral tegmental area. Brain Res Brain Res Rev 18:75-113
33. Kampman KM, Pettinati H, Lynch KG, Dackis C, Sparkman T, Weigley C, O'Brien CP (2004) A pilot trial of topiramate for the treatment of cocaine dependence. Drug Alcohol Depend 75:233-240
34. Ke Y, Cohen BM, Bang JY, Yang M, Renshaw PF (2000) Assessment of GABA concentration in human brain using two-dimensional proton magnetic resonance spectroscopy. Psychiatry Res 100:169-178
35. Ke Y, Streeter CC, Nassar LE, Sarid-Segal O, Hennen J, Yurgelun-Todd DA, Awad LA, Rendall MJ, Gruber SA, Nason A, Mudrick MJ, Blank SR, Meyer AA, Knapp C, Ciraulo DA, Renshaw PF (2004) Frontal lobe GABA levels in cocaine dependence: a two-dimensional, J-resolved magnetic resonance spectroscopy study. Psychiatry Res 130:283-293
36. Keller MB (1988) Undertreatment of major depression. Psychopharmacol Bull 24:75-80
37. Kleven M, Perry B, Woolverton W, Seiden L (1990) Effects of repeated injections of cocaine on D1 and D2 dopamine receptors in rat brain. Brain Res 532
38. Koob GF (1992) Drugs of abuse: anatomy, pharmacology and function of reward pathways. TIPS 13:177-184
39. Koob GF, Le Moal M (2001) Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology 24:97-129
40. Kushner SA, Dewey SL, Kornetsky C (1999) The irreversible gamma-aminobutyric acid (GABA) transaminase inhibitor gamma-vinyl-GABA blocks cocaine self-administration in rats. J Pharmacol Exp Ther 290:797-802
41. Leiderman DB, Shoptaw S, Montgomery A, Bloch DA, Elkashef A, LoCastro J, Vocci F (2005) Cocaine rapid efficacy screening trial (CREST): a paradigm for the controlled evaluation of candidate medications for cocaine dependence. Addiction 100(Suppl 1):1-11
42. Maas LC, Lukas SE, Kaufman MJ, Weiss RD, Daniels SL, Rogers VW, Kukes TJ, Renshaw PF (1998) Functional magnetic resonance imaging of human brain activation during cue-induced cocaine craving. Am J Psychiatry 155:124-126
43. Mason G, Petrakis I, de Graaf R, Gueorguieva R, Guidone E, Coric V, Epperson C, Rothman D, Krysta J (2005) Cortical GABA levels and the recovery from ethanol dependence: preliminary evidence of modification by cigarette smoking. Biol Psychiatry, in press
44. McFarland K, Kalivas PW (2001) The circuitry mediating cocaine-induced reinstatement of drug-seeking behavior. J Neurosci 21:8655-8663
45. McFarland K, Lapish CC, Kalivas PW (2003) Prefrontal glutamate release into the core of the nucleus accumbens mediates cocaine-induced reinstatement of drug-seeking behavior. J Neurosci 23:3531-3537
46. McLellan AT, Kushner H, Metzger D, Peters R, Smith I, Grissom G, Petttinati H, Argeriou M (1992) The fifth edition of the addiction severity index. J Subst Abuse Treat 9:199-213
47. Miller N, Millmann R (1989) The prevalence of alcohol dependence among cocaine addicts in an inpatient population. J Subst Abuse 6:37-40
48. Penney JB Jr, Young AB (1983) Speculations on the functional anatomy of basal ganglia disorders. Annu Rev Neurosci 6:73-94
49. Petroff O, Rothman D, Behar K, Collins T, Mattson R (1996) Human brain GABA levels rise rapidly after initiation of vigabatrin therapy. Neurology 47:1567-1571
50. Petroff O, Hyder F, Mattson R, Rothman D (1999) Topiramate increases brain GABA, homocarnosine, and pyrrolidinone in patients with epilepsy. Neurology 52:473-478
51. Petroff O, Hyder F, Rothman D, Mattson R (2001) Topiramate rapidly raises brain GABA in epilepsy patients. Epilepsia 42:543-548
52. Preston KL, Silverman K, Schuster CR, Cone EJ (1997) Assessment of cocaine use with quantitative urinalysis and estimation of new uses. Addiction 92:717-727
53. Rothman DL, Petroff OA, Behar KL, Mattson RH (1993) Localized 1H NMR measurements of gamma-aminobutyric acid in human brain in vivo. Proc Natl Acad Sci U S A 90:5662-5666
54. Rounsaville B, Anton S, Carroll K, Budde D, Prusoff B, Gawin F (1991) Psychiatric diagnosis of treatment-seeking cocaine abusers. Arch Gen Psychiatry 48:43-51
55. Ryner LN, Sorenson JA, Thomas MA (1995) Localized 2D J-resolved 1H MR spectroscopy: strong coupling effects in vitro and in vivo. Magn Reson Imaging 13:853-869
56. Sanacora G, Mason GF, Rothman DL, Behar KL, Hyder F, Petroff OA, Berman RM, Charney DS, Krystal JH (1999) Reduced cortical gamma-aminobutyric acid levels in depressed patients determined by proton magnetic resonance spectroscopy. Arch Gen Psychiatry 56:1043-1047
57. Sanacora G, Mason G, Rothman D, Krystal J (2002) Increased occipital cortex GABA concentrations in depressed patients after therapy with selective serotonin reuptake inhibitors. Am J Psychiatry 159:663-665
58. Sanacora G, Mason GF, Rothman DL, Hyder F, Ciarcia JJ, Ostroff RB, Berman RM, Krystal JH (2003) Increased cortical GABA concentrations in depressed patients receiving ECT. Am J Psychiatry 160:577-579
59. Sanacora G, Gueorguieva R, Epperson C, Wu Y, Appel M, Rothman D, Krystal J, Mason G (2004) Subtype-specific alterations of gamma-aminobutyric acid and glutamate in patients with major depression. Arch Gen Psychiatry 61:705-713
60. Schenk S, Snow S (1994) Sensitization to cocaine's motor activating properties produced by electrical kindling of the medial prefrontal cortex but not of the hippocampus. Brain Res 659:17-22
61. Sesack SR, Carr DB, Omelchenko N, Pinto A (2003) Anatomical substrates for glutamate-dopamine interactions: evidence for specificity of connections and extrasynaptic actions. Ann NY Acad Sci 1003:32-52
62. Spanagel R, Herz A, Shippenberg TS (1992) Opposing tonically active endogenous opioid systems modulate the mesolimbic dopaminergic pathway. Proc Natl Acad Sci U S A 89:2046-2050
63. Steffensen SC, Svingos AL, Pickel VM, Henriksen SJ (1998) Electrophysiological characterization of GABAergic neurons in the ventral tegmental area. J Neurosci 18:8003-8015
64. Stromberg M, Mackler S, Volpecelli J, O'Brien C, Dewey S (2001) The effect of gamma-vinyl-GABA on the consumption of concurrently available oral cocaine and ethanol in the rat. Pharmacol Biochem Behav 68:291-299
65. Van Bockstaele EJ, Pickel VM (1995) GABA-containing neurons in the ventral tegmental area project to the nucleus accumbens in rat brain. Brain Res 682:215-221
66. Volkow N, Fowler J (1999) Imaging studies on the role of dopamine in cocaine reinforcement and addiction in humans. J Psychopharmacol 13:337-345
67. Wald LL, Carvajal L, Moyher SE, Nelson SJ, Grant PE, Barkovich AJ, Vigneron DB (1995) Phased array detectors and an automated intensity-correction algorithm for high-resolution MR imaging of the human brain. Magn Reson Imaging 34:433-439
68. Winhusen TM, Somoza EC, Harrer JM, Mezinskis JP, Montgomery MA, Goldsmith RJ, Coleman FS, Bloch DA, Leiderman DB, Singal BM, Berger P, Elkashef A (2005) A placebo-controlled screening trial of tiagabine, sertraline and donepezil as cocaine dependence treatments. Addiction 100(Suppl 1):68-77